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Bile canaliculiHepatocytes are highly polarized cells where intercellular junctions, including tight junctions (TJs), determine
the polarity. Recently, the TJ-associated proteins claudin-1 and occludin have been implicated in hepatitis C
virus (HCV) entry and spread. Nevertheless, cell line-based experimental systems that exhibit hepatocyte-like
polarity and permit robust infection and virion production are not currently available. Thus, we sought to deter-
mine whether cell line-based, Matrigel-embedded cultures could be used to study hepatitis C virus (HCV) infec-
tion and virion production in a context of hepatocyte-like polarized cells. In contrast to standard bidimensional
cultures, Matrigel-cultured Huh-7 cells adopted hepatocyte polarization features forming a continuous network
of functional proto-bile canaliculi structures. These 3D cultures supported HCV infection by JFH-1 virus and
produced infective viral particles which shifted towards lower densities with higher associated speciﬁc infectiv-
ity. In conclusion, our ﬁndings describe a novel use of Matrigel to study the entire HCV cycle in a more relevant
context.
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In a high percentage of patients, acute hepatitis C virus (HCV) in-
fections become chronic and ultimately progress to ﬁbrosis, cirrhosis
and hepatocellular carcinoma (Poynard et al., 2003). Therapy consist-
ing of a combination of pegylated interferon-alpha plus ribavirin is
limited by a response rate of less than 50% in patients infected with
genotype 1 (Feld and Hoofnagle, 2005), which can be considerably
improved by the inclusion of the HCV protease inhibitors boceprevir
or telaprevir as part of a triple therapy (Hofmann and Zeuzem,
2011). HCV, belonging to the Flaviviridae family, is a small enveloped
RNA virus mainly transmitted by blood and other body ﬂuids
(Lindenbach and Rice, 2005). In plasma, HCV RNA-containing parti-
cles can be found associated with lipoproteins, which have been
suggested to play a role in early steps of HCV infection (Andre et al.,
2005). Multiple evidence exists for the involvement of host cell
factors in HCV entry, including glycosaminoglycans, the low-density
lipoprotein receptor, scavenger receptor class B type I (SR-BI), thets reserved.
32 F. Molina-Jimenez et al. / Virology 425 (2012) 31–39tetraspanin CD81 and the tight junction (TJ) proteins claudin-1 and
occludin (Zeisel et al., 2011).
The correct functioning of the liver is ensured by the setting and
maintenance of the highly polarized phenotype of hepatocytes. In
contact with the external environment, the apical poles of front-
facing and adjacent hepatocytes form a continuous network of bile
canaliculi (BC) where bile is secreted (Easter et al., 1983). TJs main-
tain cell polarity separating apical from basolateral membrane do-
mains and form a paracellular barrier that allows the selective
passage of certain solutes (Aijaz et al., 2006). In hepatocytes, TJs
seal the bile canaliculi and form the intercellular barrier between
bile and blood (Easter et al., 1983). Human hepatocyte-derived cell
lines susceptible to HCV infection such as Huh-7 barely form BC struc-
tures, but TJ-associated proteins such as zonula occludens protein-1
(ZO-1), occludin and claudin-1 form belts at the cell apex as in ‘sim-
ple’ polarized cells (Benedicto et al., 2008; Benedicto et al., 2009).
Thus, although TJ-associated proteins in these systems exert, at least
to some extent, their typical functions (i. e., separate apical from
basolateral domains and constitute a paracellular barrier), cellularFig. 1. Characterization of Matrigel-embedded 3D aggregates of the human hepatocyte-deri
cultures 6 and 9 days after seeding. (B and C) Cells were grown in 2D and 3D conditions for
K+-ATPase (basolateral marker) and ZO-1, green; radixin (apical marker) and GM130 (a G
merged projection of confocal stacks (XY, top) and XZ sections (bottom). 3D images show
indicate the plane from which the Z sections were taken. Z sections were compiled by ta
three separate experiments. Bar, 25 μm. (D) Cells were grown in 3D conditions and processe
XY section from the confocal stacks. Na+, K+-ATPase, green; ZO-1, red; radixin, blue; nuclemodels displaying hepatocyte-like polarity are needed to study HCV
life cycle in a more physiologically relevant context (Gondeau et al.,
2009; Perrault and Pecheur, 2009).
To date, it is not clearly established how hepatocyte polarity inﬂu-
ences HCV cycle (Perrault and Pecheur, 2009). Several attempts have
been carried out to reproduce the in vivo phenotype of hepatocytes in
3D-cultured cell lines and propagate HCV by using different kinds of
bioreactors (Sainz et al., 2009). Despite cells were susceptible to infec-
tion and produced new infectious virions, no evidence was found to
support the polarized localization of basolateral and apical markers or
the existence of functional BC-like structures. Furthermore, HepG2
cells ectopically expressing CD81 have been used as a model of polar-
ized culture to study HCV infection (Mee et al., 2009), but their restrict-
ed efﬁciency to support infection (more than 700-fold reduction
compared to Huh-7.5 cells) (Lindenbach et al., 2005; Mee et al., 2009)
limits their use as a system to study HCV assembly and egress. Recently,
it has been shown that ectopic expression of the microRNA miR-122 in
HepG2-CD81 cells increases their HCV RNA replication efﬁciency,
although infectious viral release was still 10- to 50-fold reducedved cell line Huh-7. (A) Phase contrast image (20× magniﬁcation) of 2D and 3D Huh-7
6 days and processed for double-label immunoﬂuorescence and confocal analysis. Na+,
olgi matrix protein), red; nuclei were stained with DAPI (blue). 2D images show the
a single XY section from the confocal stacks (top) and XZ sections (bottom). Arrows
king 0.5 μm steps through each XY section. Photographs are representative of at least
d for immunoﬂuorescence and confocal analysis as in (B) and (C). Images show a single
i were stained with DAPI (gray). Bar, 25 μm.
33F. Molina-Jimenez et al. / Virology 425 (2012) 31–39compared to Huh-7.5 cells (Narbus et al., 2011). Herein, we describe
that Matrigel-embedded cultures of the human hepatoma-derived cell
line Huh-7 can be used as a robust, 3D hepatocyte-like polarized system
to study the entire HCV cycle.
Results
Characterization of 3D cultures of human hepatocyte-derived cell lines
Matrigel is the trade name for a gelatinous protein mixture secret-
ed by Engelbreth–Holm–Swarm mouse sarcoma cells that resembles
the complex extracellular environment found in many tissues and is
used to produce thick 3D gels for cell culture (Kleinman and Martin,
2005). It was observed that Matrigel-cultured Huh-7 cells assembled
into 3D spheroids, whereas standard 2D-cultured cells formed the
typical epithelial monolayer (Fig. 1A). In 2D cultures, Na+, K+-ATPase
was distributed basolaterally and radixin mainly localized to the
apical pole of cells, resembling a ‘simple’ epithelial phenotype
(Fig. 1B, top). In 3D cultures, both markers were also mutually exclu-
sive; however, spheroids presented a canalicular-like radixin staining
localized at membranes surrounding the lumens within 3D aggregates
(Fig. 1B, bottomand Fig. 1D). Furthermore, in 2D cultures ZO-1was con-
ﬁned to cell-cell junctions as in cells with ‘simple’ epithelial polariza-
tion, and the Golgi apparatus did not show any speciﬁc orientation
within cells (Fig. 1C, top). In contrast, and similarly to polarized hepato-
cytes, the Golgi apparatus of spheroid-forming cells was clearly posi-
tioned between the nuclei and the lumen, whose edges were positive
for ZO-1 (Fig. 1C, bottom, Fig. 1D and Supplementary Fig. S1). Overall,
these data suggested that 3D-cultures presented hepatocyte-like polar-
ization and developed TJ-delimited canalicular structures.Fig. 2. BC-like structure and function in 2D and 3D-cultured Huh-7 cells. (A) MRP2 protein le
markers (kDa) are indicated on the right. (B) MRP2 localization after 6 days of 2D and 3D cu
projection of confocal stacks. MRP2, green; nuclei, blue. Bar, 50 μm. (C) Cells were 2D or 3D
(5 mM) or absence of Probenecid. Confocal images show the accumulation of CMFDA and CGaHepatocyte apical domain is designed for the secretion of bile into
BC (Easter et al., 1983). Among other proteins, radixin is a critical re-
quirement for the normal maintenance of the canalicular membrane
and the localization and function of its transport proteins (Wang et
al., 2006). As shown in Figs. 1B and 1D, radixin localized around the
lumen of spheroids, suggesting that the apical membranes might
behave as functional bile secretion domains. To further investigate
the functionality of these BC-like structures, we next analyzed the
expression levels and subcellular localization of the multidrug resis-
tance protein 2 (MRP2), essential for the secretory function of differ-
entiated hepatocytes. We analyzed MRP2 mRNA and protein levels
and observed no evident differences between 2D and 3D cultures
(Fig. 2A and data not shown). However, whereas in 2D cultures
MRP2 was not concentrated at any particular localization, 3D spher-
oids presented a marked accumulation of MRP2 at the membranes
delimiting the BC-like structure (Fig. 2B). Furthermore, to analyze
the cell export ability of 2D and 3D cultures, they were loaded with
the general cell stain 5-chloromethylﬂuorescein di-acetate (CMFDA)
or the conjugated bile acid analog cholylglycylamido ﬂuorescein
(CGamF) (see Materials and Methods) and visualized by confocal mi-
croscopy. 2D-cultured cells were not able to secrete the compounds,
as evidenced by a clear intracellular retention (Fig. 2C). In contrast,
spheroid-forming cells efﬁciently exported the labeled molecules to
the canalicular space where they accumulated (Fig. 2C). Interestingly,
CMFDA transport was blocked in the presence of the MRP2 inhibitor
Probenecid (Fig. 2C). These data strongly suggested that, in contrast
to standard 2D cultures, 3D spheroids developed BC-like structures
that presented vectorial trafﬁcking of compounds. In summary, 3D-
cultured Huh-7 cells displayed structural and functional polarity
features similar to hepatocytes in vivo. In order to study whethervels were analyzed byWestern blot. p53 was used as loading control. Molecular weight
lture was analyzed by confocal immunoﬂuorescence analysis. Images show the merged
cultured for 6 days, treated with 5 μM CMFDA or CGamF and washed in the presence
mF. Bar, 50 μm. Results shown are representative of at least three separate experiments.
34 F. Molina-Jimenez et al. / Virology 425 (2012) 31–39the differentiation of Huh-7 cells was improved in 3D cultures, we an-
alyzed the expression of hepatocyte-speciﬁc markers by real-time RT-
PCR and no major changes were observed (Supplementary Fig. S2).
3D cultures are susceptible to HCV infection
Firstly, we compared the expression levels of the HCV (co)recep-
tors SR-BI, CD81, occludin and claudin-1 between 2D and 3D cultures
by Western blot analysis, and no substantial differences were found
(Fig. 3A). We next analyzed whether the localization of the HCV
(co)receptors in 3D cultures was altered when compared to 2D
cultures. Similar to previous studies (Benedicto et al., 2008, 2009),
staining of occludin and claudin-1 in 2D cultures appeared to localize
at the apical poles of lateral cell membranes, the typical distribution
of these proteins in cells with ‘simple’ epithelial polarization
(Fig. 3B and Supplementary Fig. S3). However, in 3D cultures occludin
and claudin-1 seemed to present a similar localization as ZO-1
(Fig. 1 C and Supplementary Fig. S3), being mainly detected sur-
rounding the BC-like structures. These results are in agreement with
the localization of claudin-1 in polarized HepG2 cells (Harris et al.,
2010) and the distribution of occludin and claudin-1 in liver biopsiesFig. 3. 3D-cultured Huh-7 cells are susceptible to HCV infection. (A) The expression of HCV (
6 days of 2D or 3D culture. p53 was used as loading control. (B) The localization of HCV (co)
the merged projection of confocal stacks. Arrows indicate the planes corresponding to the X
three independent experiments. Bar, 50 μm. (C) Cells were grown in 2D or 3D conditions for
48, 72 or 96 h post-infection, total RNA was extracted and HCV RNA was quantiﬁed by real
(D) Cells were cultured and infected as in (C), treated with 350 UI/ml of human IFN-α2b wh
value±SD of a triplicate experiment. (E) Cells were cultured in 2D or 3D conditions for 6 d
infection, cells were processed for immunostaining using anti-core speciﬁc Ab (green). Nucle
Bar, 50 μm. Results are representative of two separate experiments.(Mee et al., 2009). Additionally, we could not show any evidence to
support that 3D conditions promoted the redistribution of CD81 and
SR-BI, which in both 2D and 3D cultures appeared distributed
throughout the plasma membrane (Fig. 3B). These results ﬁt well
with data obtained from non-polarized and polarized HepG2-CD81
cells (Mee et al., 2009). In summary, our results indicated that
embedding Huh-7 cells in Matrigel did not signiﬁcantly affect the ex-
pression levels of the HCV (co)receptors analyzed but altered the spa-
tial distribution of occludin and claudin-1, which were concentrated
at hepatocytic-like TJ structures. Nevertheless, we cannot rule out a
possible extrajunctional, diffuse localization of a pool of TJ-
associated proteins, which has been already described in other polar-
ized systems (Harris et al., 2010).
We next sought to determine whether 3D cultures were susceptible
to HCV infection.We performed infection assays using HCVcc and 2D or
3D-cultured Huh-7 cells, and monitored viral RNA at different time
points post-infection by real-time RT-PCR (Fig. 3C). We also included
controls without cells in both 2D and 3D conditions (data not shown).
HCV RNA was only detected when cells were present; in addition,
viral RNA levels increased with time, demonstrating that the signal
obtained was not due to the ampliﬁcation of Matrigel-bound inputco)receptors (occludin, CD81, claudin-1 and SR-BI) was analyzed by Western blot after
receptors was analyzed by immunoﬂuorescence and confocal analysis. XY images show
Z sections shown. Nuclei were stained with DAPI (blue). Images are representative of
6 days and infected overnight with 2D-produced HCVcc. Cells were further cultured for
-time RT-PCR. Data are represented as the mean value±SD of a triplicate experiment.
ere indicated and HCV RNA was quantiﬁed as in (C). Data are represented as the mean
ays and infected with HCVcc. A mock infection control was included. Three days after
i were stained with DAPI (blue). Images show the merged projection of confocal stacks.
Fig. 4. Viral particle production by 3D cultures and comparison with 2D-generated HCVcc. (A) 3D cultures were performed with no cells and either 293T or Huh-7 cells. After 6 days,
cultures were infected overnight with 2D-generated HCVcc, washed and fresh complete medium was added. 72 and 96 h post-infection, culture supernatants were harvested, ﬁl-
tered and used to infect naïve 2D-cultured Huh-7 cells. HCV RNA levels in target cells were determined 72 h later by real-time RT-PCR. Data are represented as the mean value±SD
of a triplicate experiment. (B) Huh-7 cells were cultured in 2D or 3D conditions for 6 days and infected overnight with 2D-produced HCVcc. After washing, cells were cultured for
96 h and supernatants were harvested, ﬁltered and titrated on 2D-cultured Huh-7.5 cells. Data from ﬁve independent viral productions are expressed as focus forming units (FFUs)/
ml and plotted as black squares (2D) or triangles (3D) including the mean values (horizontal lines). NS, not statistically signiﬁcant (P=0.175 vs. 2D, Mann–Whitney U test). (C)
HCVcc was produced in 2D or 3D conditions as in (B) and used to infect naïve Huh-7 cells that had been cultured in 2D or 3D conditions, respectively, for 6 days. Incubation of
cultures with 2 μg/ml anti-CD81 or isotype control, or a 1/100 dilution of anti-claudin-1 or control serum, was performed 1 h prior 2D or 3D-produced HCVcc infection. Retroviral
transduction of control and occludin shRNAs was performed twice, 32 and 8 h before target cell seeding. HCV RNA levels were measured by real-time RT-PCR 72 h after infection.
Results are presented as the percentage of infection of control antibody, serum or shRNA. Data are represented as the mean value±SEM of at least three independent experiments
performed in triplicate. *, Pb0.05; **, Pb0.01 versus control, paired t-test. (D) Occludin knockdown efﬁciency was evaluated by Western blot at the moment of 2D or 3D-produced
HCVcc infection. p53 was used as loading control. (E) Viral supernatants from 2D (gray area) and 3D (solid line) cultures were subjected to ultracentrifugation through 0–40% iodix-
anol gradients. Fractions were used to measure infectivity (top panel) and HCV RNA levels (middle panel). FFUs, focus forming units. Values for each fraction are expressed as the
percentage of the total of the gradient. Density is plotted as a dotted line in all panels. Data are represented as the mean value of at least four independent experiments. The bottom
panel represents the ratio between infectivity (top panel) and HCV RNA levels (middle panel).
35F. Molina-Jimenez et al. / Virology 425 (2012) 31–39HCVcc RNA. Furthermore, HCV RNA levels dropped more than ten fold
in the presence of IFN-α (Fig. 3D), strongly suggesting that productive
infection and active replicationwas taking place in both 2D and 3D con-
ditions. In order to compare HCV replication in 2D and 3D cultures, HCV
replicon-containing cells were cultured in both conditions and viralRNAwas measured by real-time RT-PCR. No differences were observed
between 2D and 3D cultures (Supplementary Fig. S4). Therefore, these
data indicated that 3D-cultured cells could be productively infected by
HCVcc and supported viral spread to a similar extent as 2D cultures,
and that viral RNA replication was not affected by embedding cells in
36 F. Molina-Jimenez et al. / Virology 425 (2012) 31–39Matrigel. To further conﬁrm the susceptibility of spheroids to be
infected, we performed immunoﬂuorescence analysis of the viral core
protein inmockorHCVcc-infectedHuh-7 cells cultured in 2Dor 3D con-
ditions (Fig. 3E). After HCVcc challenge, we clearly observed viral
protein-positive cells, demonstrating that 3D cultures were permissive
for HCVcc infection.Characterization of HCVcc produced by 3D-cultured cells
We then investigated the possible release of infectious virions
from HCVcc-infected spheroids. We found that supernatants derived
from HCVcc-infected Huh-7 spheroids were infective, and that those
collected 96 h after infection were more infective than when har-
vested 72 h post-infection (Fig. 4A). Of note, supernatants derived
from HCVcc-challenged Matrigel without cells or 3D-cultured 293T
cells, which are not susceptible to HCVcc infection (Evans et al.,
2007), were not infective (Fig. 4A). These data ruled out the possibil-
ity that supernatant infectivity was due to carry-over HCVcc from the
inoculum. Additionally, side-by-side experiments with 2D and 3D
cultures showed that HCVcc-infected 3D-cultured cells were able to
generate infectious supernatants with similar titers (~103 FFUs/ml)
as standard 2D cultures (Fig. 4B). Next, we wanted to determine
whether molecules known to mediate HCV entry in standard 2D condi-
tions are also necessary in a 3D context. As shown in Fig. 4C, anti-
claudin-1 serum and anti-CD81 antibody inhibited HCVcc infection in
both 2D and 3D cultures to a comparable extent. Similarly, occludin
knockdown (Fig. 4D) markedly reduced the susceptibility of 2D and
3D-cultured Huh-7 cells to HCVcc infection. These data strongly
suggested that CD81, claudin-1 and occludin participated in HCVcc
infection of hepatocyte-like polarized cultures.
Finally, in order to determine the density proﬁle of 2D and 3D-
generated HCVcc, culture supernatants were subjected to ultracentri-
fugation through continuous iodixanol gradients. The infectivity and
HCV RNA content of each fraction was evaluated by titration on
Huh-7.5 cells and real-time RT-PCR, respectively. Whereas infectivity
of both 2D and 3D-produced HCVcc peaked at 1.107 g/ml, fractions
below 1.107 g/ml obtained in 3D conditions consistently presented
a higher associated infectivity than those derived from 2D cultures
(Fig. 4E, top). Interestingly, 3D culture-derived supernatants showed
an almost 6-fold increase in the relative infectivity of fractions be-
tween 1.017 and 1.058 g/ml compared to 2D conditions (Table 1). Ad-
ditionally, HCV RNA peaked between 1.094 and 1.132 g/ml in both
conditions, but 3D-obtained fractions between 1.072 and 1.082 g/ml
contained approximately 3-fold higher viral RNA levels than their
2D counterparts (Fig. 4E, middle). When a ratio between infectivity
and HCV RNA was calculated, values obtained from fractions
≥1.072 g/ml were similar in both conditions (Fig. 4E, bottom); how-
ever, 3D-derived fractions between 1.04 and 1.066 g/ml presented
approximately 7- to 12-fold higher values than 2D-obtained fractions
(Fig. 4E, bottom). Collectively, these data suggested that 3D-
generated HCVcc shifted towards lower densities, and that speciﬁcTable 1
Density range and relative infectivity of grouped fractions from 2D and 3D-produced
viral supernatants. Viral supernatants from 2D and 3D cultures were subjected to ultra-
centrifugation through 0–40% iodixanol gradients. The density and infectivity of each
fraction were determined and grouped as indicated. Values for each group are
expressed as the percentage of the total of the gradient.
FFUs/ml (% of total)#
Fractions Density (g/ml)# 2D 3D
1–3 1.017 (± 0.001)≤d≤1.058 (± 0.002) 2.5±1.1 14.5±5.0*
4–6 1.066 (± 0.002)≤d≤1.082 (± 0.002) 6.0±2.7 20.4±7.5
7–9 1.094 (± 0.002)≤d≤1.132 (± 0.005) 89.1±3.1 64.2±10.9
10–12 1.166 (± 0.006)≤d≤1.302 (± 0.009) 2.3±0.8 0.9±0.3
#, mean±SEM (n=5); *, Pb0.05 vs. 2D, Mann–Whitney U test.infectivity between 1.04 and 1.066 g/ml was markedly increased in
these conditions.
Discussion
The ability to modulate hepatocyte polarity and multicellular or-
ganization is important for developing in vitro systems designed to
reproduce liver functions (Decaens et al., 2008). Extracellular matrix
modulates various cellular processes including polarization and cell
metabolism, and has been shown to maintain the phenotype of hepa-
tocytes in culture (Castell and Gomez-Lechon, 2009). Herein, we
demonstrate that Matrigel-embedded 3D cultures of Huh-7 cells, in
contrast to standard 2D conditions, form polarized aggregates that
develop TJ-delimited BC-like structures and are susceptible to
HCVcc infection, constituting an improved system for the study of
HCV and the virus-host interaction. In addition, it emerges as a suit-
able model to further characterize the contribution of polarity and
TJ-associated proteins to HCV infection in a hepatocytic polarization
context. Matrigel-embedded 3D aggregates are also able to produce
infectious HCVcc particles. Moreover, infection in a 3D-context (i. e.,
3D-generated virions employed to infect 3D cultures) is shown to
be CD81, claudin-1 and occludin-dependent. These data strongly sug-
gest that CD81, claudin-1 and occludin participate in HCVcc infection
of cultures with hepatocytic polarization. These results are in agree-
ment with recent studies in which serum-derived HCV infection of
primary human hepatocytes (PHH) was claudin-1 and CD81 depen-
dent (Fofana et al., 2010; Molina et al., 2008). To our knowledge,
this is the ﬁrst demonstration that occludin is implicated in HCV in-
fection of hepatocyte-like polarized cultures.
In plasma, HCV RNA-containing particles exhibit a wide range of
density from 1.03 to 1.30 g/ml (Andre et al., 2005). This heterogeneity
has been attributed to a varying ratio of virions to non-enveloped
cores and their variable association with host lipoproteins and/or im-
munoglobulins (Andre et al., 2005). Interestingly, in the serum of an
immunodeﬁcient, anti-HCV negative patient the majority of viral
RNA was found below 1.08 g/ml (Nielsen et al., 2006). Additionally,
a similarly narrow density range (b1.063 g/ml) was observed in a
chimpanzee with a HCV acute infection prior to the onset of immune
responses (Hijikata et al., 1993). In contrast, viral RNA from HCVcc
peaks at ~1.15 g/ml (Gastaminza et al., 2006; Lindenbach et al.,
2005, 2006; Wakita et al., 2005). Given that the higher density of in
vitro-produced HCVcc could not be due to the presence of immuno-
globulins complexed with the virions, these data suggest that HCVcc
may differ from real HCV in terms of lipoprotein association and/or
the percentage of total HCV RNA associated to naked capsids. There-
fore, infectivity associated to high density HCVcc might correspond
to viral particles that are signiﬁcantly different from real virions,
thus altering the readout of experiments. In this work, we have
shown that both infectivity and viral RNA from 3D-generated HCVcc
shift towards lower densities than HCVcc produced in 2D conditions.
Similar results have been reported with viral particles obtained from
either PHH (Podevin et al., 2010) or plasma from animals inoculated
with standard HCVcc (Lindenbach et al., 2006). Moreover, we have
shown that between 1.04 and 1.066 g/ml (fractions 2–4), despite simi-
lar relative levels of HCV RNAwere found in both 2D and 3D conditions,
the ratio infectivity/viral RNAwas 7- to 12-fold higher for 3D-generated
virions. This result suggests that infectivity of low density viral particles
is higher when they derive from 3D cultures, observation which corre-
lates well with the fact that particle density is inversely correlated to
infectivity in vivo (Hijikata et al., 1993). Collectively, these data indicate
that the nature of host cells may determine some properties of the
progeny virus, and that virions generated in a more physiological
context better resemble natural HCV.
The very low density of some natural HCV particles has been attrib-
uted to an association of the virus with ApoB and/or ApoE-positive
triglyceride-rich lipoproteins (Andre et al., 2002, 2005; Chang et al.,
37F. Molina-Jimenez et al. / Virology 425 (2012) 31–392007; Diaz et al., 2006) that might take place during viral egress
(Gastaminza et al., 2008). Similar properties have also been reported
with in vitro produced HCVcc in which virions were found to be secret-
ed in a manner that parallels the formation of very low density lipopro-
teins (VLDLs) (Chang et al., 2007; Gastaminza et al., 2006, 2008;
Meunier et al., 2008). On the other hand, early reports established a
link among cell polarization, lipoprotein secretion and virus assembly.
In highly polarized Caco-2 cells, lipoprotein secretion was shown to
be a vectorial process mainly taking place across the basolateral mem-
brane (Traber et al., 1987), and it could be enhanced by extracellular
matrix proteins (Ratcliffe et al., 2009). In addition, assembly of RNA
enveloped viruses in MDCK cells was proved to be closely related to
cell polarization (Rodriguez-Boulan et al., 1983). Thus, it is reasonable
to hypothesize that the lack of hepatocytic polarization of hepatoma-
derived 2D-cultured cells could be responsible for a defective secretion
of lipoproteins, which could in turn affect the correct assembly and
egress of viral particles. In fact, it has been demonstrated that, in con-
trast to Huh-7 and Huh-7.5 cells, the polarized cell lines HepG2 and
Caco-2 can secrete HCV glycoproteins in association with ApoB (Icard
et al., 2009). Furthermore, Huh-7-derived cells have proved to be
unable to secrete authentic, ApoB-containing VLDLs (Podevin et al.,
2010). Interestingly, the different biophysical properties observed be-
tween 2D and 3D-generated virions were not related to major changes
in differentiation-speciﬁc gene expression, but were most likely due to
the modulation of the polarization state of virus-producing cells. This
ﬁnding points to the existence of a direct link between HCV assembly
and/or egress and cellular polarization regardless of the differentiation
state. In summary, these observations suggest that in vitro-obtained
viral particles fromnon-polarized cell linesmay differ fromboth natural
HCV and virions obtained from polarized cells in terms of lipoprotein
composition or conﬁguration within the lipoviroparticle, hypothesis
which is currently being studied in our laboratory. This might explain
why, in contrast to 2D-produced HCV pseudotyped particles, HCV-like
particles and HCVcc, infection with serum-derived HCV is an LDL
receptor-dependent process (Bartosch et al., 2003; Hsu et al., 2003;
Molina et al., 2007; Triyatni et al., 2002; von Hahn et al., 2006).
Conclusions
It is largely assumed that PHH-derived systems are the best
models to mimic natural HCV infection. However, working with
PHH presents several limitations apart from ethical concerns and lo-
gistics requirements, including interindividual variability and differ-
ences in the quality of the available tissue that make it difﬁcult to
standardize both the isolation procedure and the obtained results
(Gondeau et al., 2009). Studying HCV life cycle in Huh-7-derived 3D
cultures presents the advantages of working with a cell line (homoge-
neity, unlimited availability, robust replication and virion production,
easy genetic manipulation and the possibility of performing long term
experiments) whilst maintaining hepatocytic polarity. Additionally,
at least some characteristics of 3D-produced HCVcc are similar to
those of natural HCV, thus providing a more physiologically relevant
context than standard 2D cultures. Therefore, we propose Matrigel-
embedded 3D Huh-7 cultures as a practical system that could be
used as a ﬁrst screen before validating data with PHH. We expect
that this novel, easy-made, high throughput-adaptable and reliable
model will provide a valuable tool to understand the mechanisms
governing hepatocyte HCV infection.
Materials and methods
Cell culture, generation of HCV replicon-containing clones and HCVcc
infection
293T cells and the human hepatocyte-derived cell line Huh-7 were
grown at 37 °C with a 5% CO2 atmosphere in Dulbecco's modiﬁedEagle's medium (DMEM), supplemented with 10% fetal calf serum,
2 mM L-glutamine, 50 μg/ml gentamycin, 100 U/ml penicillin and
100 μg/ml streptomycin. For 3D Matrigel-embedded cultures, 50 μl of
completemedium containing 5×103 cells was added to 50 μl of Growth
factor-reduced Matrigel with a protein concentration ranging from 7
to 7.5 μg/μl (BD Biosciences), gently mixed and deposited into either a
8-well chambered coverglass (Nalge Nunc International) or a 48-well
plate (Corning Incorporated) depending on the experiment and incu-
bated at 37 °C for 30 min. For some experiments, 3D cultures were
scaled to 24-well plates using 100 μl of complete medium containing
104 cells and 100 μl of Matrigel (see below). Cells were then covered
with complete medium and grown at 37 °C under 5% CO2 for 6 or
9 days, changing medium every 2 days. Huh-7 cells expressing full-
length or subgenomic genotype 1b (Con1, EMBL database accession
number AJ238799) HCV replicons were established as previously de-
scribed (Benedicto et al., 2008). JFH1HCVccwas produced as previously
described (Benedicto et al., 2008) and expanded in culture for several
passages. For HCVcc infection assays, 5×103 cells were grown on 2D
(24-well plates) or 3D (48-well plates) cultures for 6 days. Where indi-
cated, anti-CD81 antibody (clone JS-81, BD Biosciences), MOPC-21
mouse isotype control (Sigma), polyclonal anti-claudin-1 or preim-
mune sera (Krieger et al., 2010) were added 1 h before infection, and
cultures were infected with 103 FFUs overnight. Medium was changed
and 350 UI/ml of human IFN-α2b (PEG-Intron, Schering-Plough Corp.)
was added where indicated and replenished every 24 h. At different
times post-infection cells were processed for real-time RT-PCR or
immunoﬂuorescence (see below).Immunoﬂuorescence analysis and confocal microscopy
Cells were grown in chambered coverglasses with or without
Matrigel for 6 or 9 days. Cells were ﬁxed with 2% paraformaldehyde
for 20 min at room temperature and permeabilized with 0.5%
TritonX-100 in PBS for 10 min at room temperature. Cells were
rinsed three times with 100 mM glycine in PBS for 15 min and
blocked with TNB [0.1 M Tris–HCl, 0.15 M NaCl, 0.5% blocking re-
agent (Boehringer Mannheim GmbH)] plus 10% goat serum from
Sigma for 2 h at 37 °C. Cells were incubated with the indicated anti-
bodies diluted in TNB overnight at room temperature and after
washing with 0.1% NP-40 in PBS, cells were incubated with Alexa
488, Alexa 647 or rhodamine X-conjugated goat anti-mouse or
anti-rabbit antibodies (Molecular Probes, Inc.) for 2 h at 37 °C and
counterstained with DAPI (Pierce). For multiple stainings, samples
were incubated sequentially with the indicated primary and sec-
ondary antibodies. The preparations were analyzed with a Leica TCS-
SP5 (Leica Microsystems) confocal microscope. Antibodies used
were: monoclonal anti-Na+, K+-ATPase (Abcam), anti-GM130 (BD
Bioscencies), anti-MRP2 (M2 III-6; Alexis Laboratories), anti-CD81
(clone 1.3.3.22, Santa Cruz Biotechnology), anti-occludin (Zymed),
polyclonal anti-radixin (Cell Signaling Technology), anti-ZO-1, anti-
occludin, anti-claudin-1 (Zymed), anti-SR-BI (Novus Biologicals)
and the monoclonal antibody against HCV core (clone C7-50, Afﬁnity
BioReagents) protein.Western blots
5×103 cells were grown on 48-well plates for 3D Matrigel cul-
tures or 24-well plates for 2D conventional cultures for 6 to 9 days.
Cells were lysed on the plate with 100 μl of Laemmli buffer and boiled
for 5 min. Western blots were carried out as previously described
(Benedicto et al., 2008) with the following antibodies: polyclonal
anti-occludin, anti-claudin-1 and anti-SR-BI and monoclonal anti-
MRP2 (see above), anti-CD81 (clone 5A6) and anti-p53 (Santa Cruz
Biotechnology).
38 F. Molina-Jimenez et al. / Virology 425 (2012) 31–39Characterization of hepatocyte-like polarity
Functional BC, those that exhibited an accumulation of 5-
chloromethylﬂuorescein di-acetate (CMFDA) or cholylglycylamido
ﬂuorescein (CGamF), were determined by confocal analysis of ﬂuo-
rescent compounds (Bogman et al., 2003; Bravo et al., 1998;
Lindenmaier et al., 2005). The nonﬂuorescent lipophilic CMFDA
(Molecular Probes) passively penetrates the plasma membrane.
Inside the cells, cytosolic esterases cleave off its acetate residues,
thereby releasing the ﬂuorescent and membrane-impermeable prod-
uct 5-chloromethylﬂuorescein (CMF), which can react (e.g., with glu-
tathione) to form ﬂuorescent conjugates. This methylﬂuorescein-
glutathione complex is then actively secreted by MRP2 (Bogman et
al., 2003). The conjugated bile salt CGamF was synthesized by binding
FITC to glycocholate at the carboxyl group following a previously de-
scribed method (Sherman and Fisher, 1986). This ﬂuorescent bile salt
derivative has been used to determine hepatocyte polarity-associated
vectorial transport towards BC-like structures into which CGamF is
secreted (Cantz et al., 2000). Cells were grown into chambered cover-
glasses with or without Matrigel for 6 days and incubated with 5 μM
of either CMFDA or CGamF in culture medium for 20 min at 37 °C.
Cells were rinsed four times with fresh medium in the presence
(5 mM) or absence of the MRP2 inhibitor Probenecid (Sigma) where
indicated and the accumulation of ﬂuorescent products was analyzed
with a confocal microscope.
RT-PCR
RNA extraction, reverse transcription and quantitative PCRwere per-
formed as previously described (Benedicto et al., 2008). Speciﬁc primers
usedwere: HCV, H3 (Benedicto et al., 2008) andMRP2 (Briz et al., 2007)
as previously described; HNF4α, 5′-CGGAAGAACCACATGTACTC-3′ and
5′-TGCTGTCCTCATAGCTTGAC-3′; α1AT, 5′-TCAAGGAGCTTGACAGA-
GAC-3′ and 5′-GACAGCTTCTTACAGTGCTG-3′; TTR, 5′-GCTGGACTGG-
TATTTGTGTC-3′ and 5′-ACTCACTGGTTTTCCCAGAG-3′; albumin, 5′-
TGTGTTGCTGATGAGTCAGC-3′ and 5′-ACATCAACCTCTGGTCTCAC-3′;
CYP3A5, 5′-GGAGAGCACTAAGAAGTTCC-3′ and 5′-TGTCGTTGAGGC-
GACTTTTC-3′; UGT1A1, 5′-ACAGAACTTTCTGTGCGACG-3′ and 5′-CCA-
CAATTCCATGTTCTCCAG-3′. Histone H3 mRNA levels were used for
sample normalization.
Short hairpin RNA (shRNA) retroviral transfer
Generation of control and occludin shRNA retroviral vectors, pro-
duction of retroviral particles and infection was performed as previ-
ously described (Benedicto et al., 2009). 5×103 transduced cells
were reseeded in 2D (24-well plates) or 3D (48-well plates) cultures
8 h after the last transduction. Cells were grown for 6 days and either
infected with HCVcc or lysed to check knockdown efﬁciency by West-
ern blot (see above).
Iodixanol gradient ultracentrifugation of 2D and 3D-generated HCVcc
104 cells were seeded in 2D (12-well plates) and 3D (24-well plates)
conditions. After 6 days, cells were HCVcc infected overnight, washed
and 1 ml of complete medium per well was added. 96 h post-infection
the supernatants were harvested, ﬁltered through 0.45-μm pore-sized
membranes and concentrated 5-fold in a 100,000molecularweight cut-
off Spin-XUF6 Concentrator (Corning Incorporated) at 4 °C. Continuous
0–40% iodixanol gradients were prepared using Optiprep (Axis-Shield).
5.5 ml of 40% iodixanol in 83 mMsucrose, 1 mMEDTA and 10 mMTris–
HCl pH 7.4 were layered with 5.5 ml of homogenization media
(250 mM sucrose, 1 mM EDTA and 10 mM Tris–HCl pH 7.4) and the
gradients were formed with a Gradient Master (BioComp Instruments,
Inc.). 1 ml of the concentrated viral supernatant was loaded on top of
the gradient and tubes were subjected to ultracentrifugation in aSW41 rotor (Beckman Coulter) at 31,000 rpm and 4 °C for 16 h. 1 ml
fractions were collected from the top and titration was performed by
infection of Huh-7.5 cells with serially diluted fractions and staining
with anti-core antibody. Viral RNA levels were measured by extracting
RNA from 100 μl of each fraction with 900 μl of TRI Reagent (Ambion
Inc.), using 20 μg of glycogen (Roche Diagnostics GmbH) as a carrier
for RNA precipitation, and performing real-time RT-PCR (see above).
Density of fractions was calculated using a refractometer (EUROMEX
microscopen BV).
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